Levodopa in Parkinson’s Disease: Current Status and Future Developments

2017272 citationsReviewbronze Open Access

Authors

Nicola Tambasco · Azienda Ospedaliera di Perugia

Michele Romoli · Azienda Ospedaliera di Perugia

Paolo Calabresi · Azienda Ospedaliera di Perugia

Abstract

New LD formulations, oral compounds as well as routes have been tested in the last years, with two main targets: achieve continuous dopaminergic stimulation and find an instant deliver route for LD.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Autism Spectrum Disorder Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Neuropharmacology

Volume 16, Issue 8, pp. 1239-1252

DOI: 10.2174/1570159x15666170510143821

Field-Weighted Citation Impact: 7.55